Search results
Results From The WOW.Com Content Network
Purdue argued—and the bankruptcy court and 2nd Circuit agreed—that three key sections of the bankruptcy code, taken together, authorize a bankruptcy court to grant such releases: sections 105 ...
The Supreme Court in August 2023 paused bankruptcy proceedings concerning Purdue and its affiliates when they agreed to take up the administration's appeal of the 2nd Circuit's ruling. Lawsuits ...
Title 11 of the United States Code. Harrington v. Purdue Pharma L.P., (Docket No. 23-124), is a United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code. [1] This case is about the settlement by Purdue Pharmaceutical for opioid victims who overdosed with the OxyContin drug produced by their company.
Bottles of Purdue Pharma L.P. OxyContin medication sit on a pharmacy shelf in Provo, Utah on Aug. 31, 2016. ... the New York-based 2nd U.S. Circuit Court of Appeals approved the plan over the ...
The New York-based 2nd Circuit U.S. Court of Appeals last year approved the plan over the objection of William Harrington, the U.S. government trustee monitoring the bankruptcy.
The United States Court of Appeals for the Second Circuit (in case citations, 2d Cir.) is one of the thirteen United States Courts of Appeals. Its territory covers the states of Connecticut, New York, and Vermont, and it has appellate jurisdiction over the U.S. district courts in the following federal judicial districts : District of Connecticut.
Purdue’s lawyer said the net worth of the “small number” Sackler family members who served as directors and officers in the company in the US is roughly $1.2 billion. A decision in the case ...
Purdue Pharma on Tuesday asked a U.S. bankruptcy judge for a 60-day freeze on lawsuits against its owners, members of the wealthy Sackler family, in its first court appearance since a landmark ...